Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04674852 · ClinicalTrials.gov registry record · NA
Mayo Designed Soft Tissue Ultrasound-Detectable Marker
A NA study of Breast Neoplasm Female and Ultrasound Therapy; Complications, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT04674852: Completed NA study of Breast Neoplasm Female and Ultrasound Therapy; Complications, sponsored by Mayo Clinic.
NCT04674852 is a NA study of Breast Neoplasm Female and Ultrasound Therapy; Complications that has completed, run by Mayo Clinic. The registered enrollment target is 8 participants, below the 179-participant average among 8 other Breast Neoplasm Female trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04674852, a NA study of Breast Neoplasm Female and Ultrasound Therapy; Complications, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are trying to determine if the Mayo marker is easily seen with ultrasound making it easier, faster, and more accurate for preoperative localization of the biopsied positive lymph node.
Primary Outcome
Evaluation of ultrasound conspicuity of marker placed at time of radioactive seed localization.
Conditions Studied
Interventions
- DEVICE Research Marker
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-11-02 |
| Est. Completion | 2022-04-07 |
| Phase | NA |
What the finished NCT04674852 record still lists
NCT04674852 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 179-participant average among 8 other Breast Neoplasm Female trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Breast Neoplasm Female appearing as the primary indexed condition, and to 1 intervention - of which Research Marker is the first listed.
NCT04674852 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04674852 about?
NCT04674852 is a clinical study titled "Mayo Designed Soft Tissue Ultrasound-Detectable Marker". Researchers are trying to determine if the Mayo marker is easily seen with ultrasound making it easier, faster, and more accurate for preoperative localization of the biopsied positive lymph node.
What is the current status of trial NCT04674852?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2020-11-02. Estimated completion is 2022-04-07.
What conditions does trial NCT04674852 study?
This clinical trial studies the following conditions: Breast Neoplasm Female, Ultrasound Therapy; Complications.
What interventions are being tested in trial NCT04674852?
The interventions under investigation include: Research Marker (DEVICE).
Who is sponsoring clinical trial NCT04674852?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04674852 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Neoplasm Female
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04674852's enrollment target sits among peer trials
8 9th of 8 the lowest of 8 other Breast Neoplasm Female trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Neoplasm Female trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy
RECRUITING · NA
-
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
RECRUITING · NA
-
Study on Physical Activity's Relationship With Cancer and Cognition
COMPLETED · NA
-
Web-Base App To Improve Aromatase Inhibitor Adherence
COMPLETED · NA
-
THRIVE Breast Cancer App Study
COMPLETED · NA
-
Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI